Alpha‐actinin‐4 (ACTN4) gene amplification is a predictive biomarker for adjuvant chemotherapy with tegafur/uracil in stage I lung adenocarcinomas

Although adjuvant tegafur/uracil (UFT) is recommended for patients with completely resected stage I non‐small‐cell lung cancer (NSCLC) in Japan, only one‐third of cases has received adjuvant chemotherapy (ADJ) according to real‐world data. Therefore, robust predictive biomarkers for selecting ADJ or...

Descripción completa

Detalles Bibliográficos
Autores principales: Noro, Rintaro, Honda, Kazufumi, Nagashima, Kengo, Motoi, Noriko, Kunugi, Shinobu, Matsubayashi, Jun, Takeuchi, Susumu, Shiraishi, Hideaki, Okano, Tetsuya, Kashiro, Ayumi, Meng, Xue, Yoshida, Yukihiro, Watanabe, Shunichi, Usuda, Jitsuo, Inoue, Tatsuya, Wilber, Huang, Ikeda, Norihiko, Seike, Masahiro, Gemma, Akihiko, Kubota, Kaoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898703/
https://www.ncbi.nlm.nih.gov/pubmed/34845792
http://dx.doi.org/10.1111/cas.15228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898703/
https://www.ncbi.nlm.nih.gov/pubmed/34845792
http://dx.doi.org/10.1111/cas.15228

Ejemplares similares